GemPharmatech
Business Services · Delaware, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1521 Concord Pike Ste 301, Wilmington, D...Phone Number
(888) 899-5899Website
www.gempharmatech.usRevenue
$47.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GemPharmatech
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models.Explore more
GemPharmatech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GemPharmatech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at GemPharmatech
Earning: See what the market has to say on GemPharmatech recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if GemPharmatech is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if GemPharmatech had a recent Job posting/layoffs
Funding: Get notified immidiatlly once GemPharmatech has new funding data
GemPharmatech, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when GemPharmatech launches new products
Check if GemPharmatech has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined GemPharmatech as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
GemPharmatech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GemPharmatech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GemPharmatech.
GemPharmatech Tech Stack
A closer look at the technologies used by GemPharmatech
See more technologies
Most Recent Scoops
Person-Based
Project
A mid-level source in Product Management has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to third-party libraries within the next six to nine months. GemPharmatech is currently evaluating pandas and Telerik. The organization will be increasing investments and is considering the use of a contingent workforce to support these efforts.
Spending/Investment, Request for Proposal (RFP), Engineering, Contingent Workforce, Financial Planning, Product Management, Outsourcing
Project
A mid-level source in Product Management has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to application lifecycle management (ALM) within the next three to six months. GemPharmatech is currently evaluating ENOVIA by Dassault Systèmes and Oracle Fusion Cloud PLM. The organization will be decreasing investments and is expected to use a contingent workforce to support these efforts.
Cloud, Spending/Investment, Application Development, Request for Proposal (RFP), Contingent Workforce, Financial Planning, Product Management, Software
Project
A mid-level source in Product Management has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to web development within the next six to nine months. GemPharmatech is currently evaluating MAMP and Weebly. The organization will be decreasing investments and is considering the use of a contingent workforce to support these efforts.
Spending/Investment, Collaboration/Web Apps, Application Development, Request for Proposal (RFP), Website, Contingent Workforce, Financial Planning, Product Management
Project
Request for Proposal (RFP), Contingent Workforce, Product Management, User Interface
GemPharmatech News & Media
GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG Portfolio
WILMINGTON, Del., July 26, 2022 /PRNewswire/ -- In order to bring new cutting-edge research models to the market to accelerate the development of novel therapeutics for a host of unmet medical needs, particularly in immuno-oncology, GemPharmatech (GemPharmatech Co., Ltd.) announced that...GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange
WILMINGTON, Del.--(BUSINESS WIRE)--GemPharmatech LLC is pleased to announce that April 25, its parent company, GemPharmatech Co., Ltd., went public on the Shanghai Stock Exchange.GemPharmatech Presents Humanized Mouse Models to Support Bispecific Antibody and COVID-19 Preclinic Development at Biologics UK Oxford Global Conference
WILMINGTON, Del.--(BUSINESS WIRE)--GemPharmatech (GemPharmatech Co., Ltd. “GPT”) presented its humanized mouse models to support T-Cell Bispecific antibody and COVID-19 preclinic development and co-hosted a panel discussion on bispecific antibodies at Biologics UK Oxford Global Conference, London, UK, Sept. 6-8, 2021. The conference is the biggest in-person biologics event in London and was attended by hundreds of industrial and academic researchers and business partners from around the globe.GemPharmatech and UC Davis Sign Agreement to Distribute Mouse Models in the US to Better Serve US Academic and Pre-Clinical R&D Communities
WILMINGTON, Del.--(BUSINESS WIRE)--GemPharmatech and UC Davis Mouse Biology Program team up providing faster mouse model services for pre-clinical research and development in the US.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding GemPharmatech
Sign Up For FreeTo access detailed company insights
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models.... Read More
